Back
Arcutis Biotherapeutics, Inc. Stock Price Chart
This Tech Company Grew 32,481%...
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Buy
68
ARQT
Arcutis Biotherapeutics, Inc.
Last Price:
$26.97
Seasonality Move:
-8.25%
7 Day Trial
ALL ACCESS PASS
$
7
-
The current trend is moderately bullish and ARQT is experiencing buying pressure, which is a positive indicator for future bullish movement.
Arcutis Biotherapeutics, Inc. Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 26.94 | Buy |
| 20-day SMA: | 26.54 | Buy |
| 50-day SMA: | 27.34 | Buy |
| 200-day SMA: | 20.63 | Buy |
| 8-day EMA: | 27.1 | Buy |
| 20-day EMA: | 26.83 | Buy |
| 50-day EMA: | 26.76 | Buy |
| 200-day EMA: | 22.08 | Buy |
Arcutis Biotherapeutics, Inc. Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.08 | Buy |
| Relative Strength Index (14 RSI): | 59.58 | Buy |
| Chaikin Money Flow: | 2983128 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (25.72 - 27.22) | Buy |
| Bollinger Bands (100): | (22.88 - 29.36) | Buy |
Arcutis Biotherapeutics, Inc. Technical Analysis
| Feb 12 | Feb 13 | Feb 17 | Feb 18 | Feb 19 | Feb 20 | Feb 23 | Feb 24 | Feb 25 | Feb 26 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Feb | ||||||||||
| 12 | 13 | 17 | 18 | 19 | 20 | 23 | 24 | 25 | 26 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Arcutis Biotherapeutics, Inc. Stock
Is Arcutis Biotherapeutics, Inc. Stock a Buy?
-
Arcutis Biotherapeutics, Inc. share price is 28.57 while ARQT 8-day simple moving average is 26.94, which is a Buy signal.
-
The stock price of ARQT is 28.57 while Arcutis Biotherapeutics, Inc. 20-day SMA is 26.54, which makes it a Buy.
-
Arcutis Biotherapeutics, Inc. 50-day simple moving average is 27.34 while ARQT share price is 28.57, making it a Buy technically.
-
ARQT stock price is 28.57 and Arcutis Biotherapeutics, Inc. 200-day simple moving average is 20.63, creating a Buy signal.
ARQT Technical Analysis vs Fundamental Analysis
Buy
68
Arcutis Biotherapeutics, Inc. (ARQT)
is a Buy
Is Arcutis Biotherapeutics, Inc. a Buy or a Sell?
-
Arcutis Biotherapeutics, Inc. stock is rated a BuyThe current Arcutis Biotherapeutics, Inc. [ARQT] share price is $28.57. The Score for ARQT is 68, which is 36% above its historic median score of 50, and infers lower risk than normal.
Arcutis Biotherapeutics, Inc. Stock Info
Market Cap:
3.5B
Price in USD:
28.57
Share Volume:
3.4M
Arcutis Biotherapeutics, Inc. 52-Week Range
52-Week High:
31.77
52-Week Low:
11.86
Buy
68
Arcutis Biotherapeutics, Inc. (ARQT)
is a Buy
Arcutis Biotherapeutics, Inc. Share Price Forecast
-
What is the Arcutis Biotherapeutics, Inc. stock price today?The Arcutis Biotherapeutics, Inc. stock price is 28.57 USD today.
-
Will ARQT stock go up or go down?Arcutis Biotherapeutics, Inc.> share price is forecast to RISE/FALL based on technical indicators
-
Is Arcutis Biotherapeutics, Inc. overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Arcutis Biotherapeutics, Inc. is not overvalued.
Is Arcutis Biotherapeutics, Inc. Stock a Buy?
-
Arcutis Biotherapeutics, Inc. share price is 28.57 while ARQT 8-day exponential moving average is 27.10, which is a Buy signal.
-
The stock price of ARQT is 28.57 while Arcutis Biotherapeutics, Inc. 20-day EMA is 26.83, which makes it a Buy.
-
Arcutis Biotherapeutics, Inc. 50-day exponential moving average is 26.76 while ARQT share price is 28.57, making it a Buy technically.
-
ARQT stock price is 28.57 and Arcutis Biotherapeutics, Inc. 200-day simple moving average is 22.08, creating a Buy signal.
Fundamental Analysis of Arcutis Biotherapeutics, Inc.
Is Arcutis Biotherapeutics, Inc. a good investment?
-
Analysts estimate an earnings increase this quarter of $0.28 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.65 per share, and an increase next year of $0.85 per share.
Technical Analysis of Arcutis Biotherapeutics, Inc.
Should I short Arcutis Biotherapeutics, Inc. stock?
-
ARQT Moving Average Covergence Divergence (MACD) indicator is 0.08, suggesting Arcutis Biotherapeutics, Inc. is a Buy
-
Arcutis Biotherapeutics, Inc. Relative Strength Index (RSI) is 59.58, which suggest Arcutis Biotherapeutics, Inc. is overbought
-
The Bollinger Bands (25) for Arcutis Biotherapeutics, Inc. is (25.72 - 27.22), which suggest Arcutis Biotherapeutics, Inc. is a Buy
-
The Bollinger Bands (100) for Arcutis Biotherapeutics, Inc. is (22.88 - 29.36), which suggest Arcutis Biotherapeutics, Inc. is a Buy
* Arcutis Biotherapeutics, Inc. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.